No title
Tuberculosis (TB) affects millions of people annually and remains one of the leading causes of infectious diseases-related deaths in the world. Current anti-TB treatment consists of a prolonged regimen of multiple antibiotics, which effectively eliminates the bacteria when it is not antibiotic resistant. However, large proportions of the TB-treated individuals experience persistent pulmonary dysfu
